ITCI - Intracellular Th - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITCI is currently covered by 9 analysts with an average price target of $138.19. This is a potential upside of $6.32 (4.79%) from yesterday's end of day stock price of $131.87.

Intracellular Th's activity chart (see below) currently has 268 price targets and 178 ratings on display. The stock rating distribution of ITCI is 35.71% BUY and 64.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.16% with an average time for these price targets to be met of 482 days.

Highest price target for ITCI is $132, Lowest price target is $102, average price target is $128.25.

Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 23-Feb-2025. First documented stock forecast 13-Apr-2015.

Currently out of the existing stock ratings of ITCI, 5 are a BUY (35.71%), 9 are a HOLD (64.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$132

$0.13 (0.10%)

$100

7 months 24 days ago
(23-Feb-2025)

10/11 (90.91%)

$3.43 (2.67%)

292

Hold

$100

7 months 27 days ago
(20-Feb-2025)

21/22 (95.45%)

$-27.19 (-21.38%)

170

Hold

$132

$0.13 (0.10%)

$87

8 months 13 days ago
(04-Feb-2025)

8/9 (88.89%)

$4.97 (3.91%)

221

Hold

$132

$0.13 (0.10%)

$113

8 months 17 days ago
(30-Jan-2025)

12/13 (92.31%)

$4.92 (3.87%)

738

Buy

$132

$0.13 (0.10%)

$89

8 months 21 days ago
(26-Jan-2025)

10/11 (90.91%)

$4.79 (3.77%)

39

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITCI (Intracellular Th) average time for price targets to be met?

On average it took 482 days on average for the stock forecasts to be realized with a an average price target met ratio 93.16

Which analyst has the current highest performing score on ITCI (Intracellular Th) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on ITCI (Intracellular Th)?

Sumant Kulkarni works at CANACCORD and has 3 price targets and 2 ratings on ITCI

Which analyst is the currently most bullish on ITCI (Intracellular Th)?

David Amsellem with highest potential upside - $0.13

Which analyst is the currently most reserved on ITCI (Intracellular Th)?

Edward Nash with lowest potential downside - -$103.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?